Description

Social Media Moderator – Mark Drazner

Results From the Pediatric Heart Network’s Fonta n Udenafil Exercise Longitudinal Trial – David Goldberg

Discussant – Craig Sable

Effect of Treatment According to Age in the Dapagliflozin and Prevention of Adverse-Outcomes in Heart Failure Trial (DAPA-HF) – Felipe Martinez

Effect of Treatment on the Kansas City Cardiomyopathy Questionnaire (KCCQ) in the Dapagliflozin and Prevention of Adverse-Outcomes in Heart Failure Trial (DAPA-HF) - John McMurray

Discussant – Carolyn Lam

LBCT: Effects of Sacubitril/Valsartan in Women Compared to Men With Heart Failure and Preserved Ejection Fraction - John McMurray

Effect of Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure - Scott Solomon

Discussant – Lynne Stevenson

Putting It All Together: How to Use SGLT2 Inhibitors and ARNIs in Practice – Clyde Yancy

Late Breaking Science V: Challenges in Heart Failure Management – Discussion

Speaker(s):

• Panel Discussion
• Felipe Martinez
• Mark Drazner
• David Goldberg
• Craig SABLE
• Felipe Martinez
• John McMurray
• Carolyn Lam
• Scott Solomon
• Lynne Stevenson
• Clyde Yancy